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The synthesis of glycyl-L-histidyl-L-lysine, glycyl-L-lysyl-
-L-histidine, L-tyrosyl-L-histidyl-L-lysine, N-,N-e,-N-e-tribenzy lo-
xycarbonyl derivative of L-histidyl-L-lysyl-L-lysine methyl ester, 
L-histidy 1-L-tyrosy 1-L-lysine, and L-tyrosy 1-L-histidy 1-L-lysyl-L-ly-
sine by adoption of the azide coupling approach is described. · 
Hypothalamic peptides continue to be a topic of very great interest1 . The 
difficulties in identifying and isolating all protein hormones and releasing 
factors from anterior pituary glands are not only due to their minute quantities 
in tissue but also to bioassay problems. Synthesis and assay of oligopeptide 
analogues of these biologically important molecules should allow a better 
molecular interpretation of their physiology. This is especially true for the 
releasing hormone peptides because they can be expected to guide us even 
in the design of antagonists of greater interest than the hormone themselves. 
Looking back, fundamental advances in endocrinology and physiology often 
became possible after an active peptide had been made available synthetically 
in large quantity and adequate purity. 
Some of the lysine containing tripeptide growth promoting factors have 
recently been isolated from human serum and identified as glycyl-L-histidyl-
-L-lysine2-4 (I) and glycyl-L-lysyl-L-histidine1 (II). Synthetic tripeptide I, obtained 
by a solid-phase method2, also possessed the protective and growth stimulating 
properties of a factor normally present in human serum. In recent years, 
largely as a result of our continuing search for biologically active oligopep-
tidess-7, we have synthesized the lysine containing tripeptides I and II by 
classical fragment condensation in order to compare them with the polyfunctio-
nal L-tyrosyl-L-histidyl-L-lysine (III) in biological functions related to those 
of growth hormones. Results reported earlier2- 4 indicated that 
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normal human serum contains a highly polar tripeptide which stimulates 
essential biosynthetic effects of serum in mammalian cell cultures. Preliminary 
biological testing with tripeptides I , II, and III revealed that the polyfunctional 
tripeptide III to stimulate, even in nanometric concentrations, the in vitro incor-
poration of labelled sulphate into embryonic chick cartilages,o, without the 
presence of mediating serum factors. It was also established that tripeptide 





















































L ys ( I) 
His (II) 
Tyr (III) 
z = benzyloxycarbonyl, Bzl = benzyl, OSu = hydroxysuccinimide, Gly = glycine, 
His = L-histidine, Lys = L-lysine, Tyr = L-tyrosine, a 0-protection of Tyr only, 
" N-i:--protection of Lys only. 
Scheme 1 outlines the syntheses of tripeptides I, II, and III. The benzylo-
xycarbonyl derivatives of glycyl-L-histidine10, 11 (IV), glycyl-N-i::-benzyloxycar-
bonyl-L-lysine12 (V), and 0-benzyl-L-tyrosyl-L-histidine (VI) methyl esters were 
first converted into their corresponding hydrazides VII10,13, VIIP2, IX and then 
to their active azides. The imidazole nitrogen of histidine was kept unprotected. 
The azides, prepared from hydrazides VII and IX, were then coupled10 with the 
N-i::-benzyloxycarbonyl-L-lysine methyl ester14 to yield N-benzyloxycarbonyl-
-glycyl-L-histidyl-N-i::-benzyloxycarbonyl-L-lysine methyl ester (X) and N-ben-
zyloxycarbonyl-0-benzyl-L-tyrosyl-L-histidyl-N-i::-benzyloxycarbonyl-L-lysine 
methyl ester (XII), respectively. The azide, obtained from hydrazide VIII, in 
reaction with L-histidine methyl ester produced N-benzyloxycarbonyl-glycyl-
-N-i::-benzyloxycarbonyl-L-lysyl-L-histidne methyl ester (XI). 
The N-protected tripeptide methyl esters X, XI, and XII were first saponi-
fied to the corresponding N-protected tripeptide acids and their N-debenzylo-
xycarbonyls removed by hydrogenolysis to give the free tripeptides I, II, and 
III. The sequence of tripeptide I, as its N-t-butoxycarbonyl derivatives XIII was 
also built up by elongation of N-t-butoxycarbonyl-glycyl-L-histidine methyl 
ester (XIV). 
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In order to prepare polyfunctional tripeptides in which the histidyl unit 
was followed by two trifunctional amino acids the N-t-butoxycarbonyl deri-
vatives of N-£-benzy loxycarbony 1-L-lysy 1-N-£-benzy loxycar bony 1-L-lysine 
SCHEME 2 
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His Tyr Lys (XIX) 
a 0-protection 'of Tyr only, b N-s-protection of Lys only. 
methyl ester15 (XV) and 0-benzyl-L-tyrosyl-N-£-benzyloxycarbonyl-L-lysine 
benzyl ester (XVI), being first N-deprotected by trifluoroacetic acid, was reacted 
with the freshly prepared N-benzyloxycarbonyl-L-histidine azide13 under 
coupling conditions known to lead to minimal racemization. Scheme 2 summa-
rizes the synthetic pathways for N-benzyloxycarbonyl-L-histidyl-N-£-benzyl-
oxycarbonyl-L-lysyl-N-£-benzyloxycarbonyl-L-lysine methyl ester (XVII) and 
N-benzyloxycarbonyl-L-histidyl-0 -benzyl-L-tyrosyl-N-£-benzyloxycarbonyl-L-
-lysine benzyl ester (XVIII), the latter being blocked with hydrogenolytically 
removable N-benzyloxycarbonyl and 0-benzyl groups. Thus, the hydrogenolysis 
of XVIII in ethanol over a mixture of 100/o Pd/C and Pd-black catalyst pro-
duced L-histidyl-L-tyrosyl-L-lysine (XIX) in high yields. If acetic acid (20/o 
v/v) was added the reactions was accelerated. 
SCHEME 3 
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TABLE I 
Compound M. p./°C Solvent RF Yield Mol. Ofo weight 
Di peptides 
Z-Tyr-Bzl-His-OMe (VI) 115--117 EtOAc 0.40 78 556.6 
Z-Tyr-Bzl-His-NHNH2 (IX) 207-210 MeOH 85 556.6 
N-s-Z-Boc-Lys-N-£-Z-Lys-OMe (XV) 108-110 •EtOAc-n- 0.50 93 656.76 
(95-97) 14 -hexane 
Boc-Tyr-Bzl-N-£-Z-Lys-OBzl (XVI) 117-119 EtOAc- 0.65 62.6 723.84 
-Et20 
Boc-Tyr-Bzl-His-OMe (XXII) 121-123 EtOAc- 0.70 77 522.58 
-Et20 
Boc-Tyr-Bzl-N-E-Z-Lys-OMe (XXIII) 165-166 EtOAc 0.87 91.6 647.74 
Z-Tyr-Bzl-N-£-Z-Lys-OMe (XXIV) 152-154 EtOAc 0.85 81 681.76 
Z-Tyr-Bzl-N-£-Z-Lys-NHNH2 (XXV) 169-172 EtOH 0.60 88 681.76 
Tri peptides 
H-Gly-His-Lys-OH (I) foam H20 83/871' 358.40 
H-Gly-Lys-His-OH (II) foam H20 74/89'' 358.40 
H-Tyr-His-Lys-OH (III) foam H20 100/941' 446.50 
Z-Gly-His-N-s-Z-Lys-OMe (X) 165-166 EtOH 0.70 75 622.70 
Z-Gly-N-£-Z-Lys-His OMe (XI) 125-128 EtOAc- 0.65 70 622.66 
-Et2-0-n-
-hexane 
Z-Tyr-Bzl-His-N-£-Z-Lys-OMe (XII) 162-165 600/o EtOH 0.33 70 836.91 
Boc-Gly-His-N-£-Z-Lys-OMe (XIII) 158-160 EtOH 0.40 59 588.65 
Z-His-N-£-Z-Lys-N-£-Z-Lys-OMe (XVII) 125-126 EtOAc- 0.38 34.2 827.91 
-Et20 
Z-His-Tyr-Bzl-N-£-Z-Lys-OBzl (XVIII) 187-189 MeOH 0.55 70 894.99 
H-His-Tyr-Lys-OH (XIX) foam H20 95 446.50 
Tetra peptides 
Z-Tyr-Bzl-His-N-£-Lys-N-s-Z-Lys-OMe (XX) 182-184 MeOH 0.40 88 1081.90 
H-Tyr-His-Lys-Lys-OH (XXI) foam H20 59/93'' 574.67 
• 
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TABLE I (Cont.) 
Anal. Calc'd: 
Formula Found: Vmax/cm-1 
0/oC O/oH O/oN 
C31H32N40 6 66.89 5.80 10.07 3333, 1754, 1721, 1656, 1613, 
66.71 6.01 10.28 1543, 1515, 1236br, 740, 697 
C30H 32N60 s 64.73 5.80 15.10 3378, 1704, 1661, 1639, 1534br, 
64.52 5.49 14.83 1513br, 1263br, 1233br, 740, 694 
C34H4sN40 9 62.17 7.37 8.53 3444, 1777, 1695, 1668, 
62.20 7.60 8.82 1537br, 1257, 754, 693 
C42H 49N30 s 69.68 6.82 5.81 3408, 1728, 1684, 1648, 1608, 1533br, 
69.57 6.97 6.1? 1519br, 1510, 1240, 790, 689 
C2sH 34N40 6 64.35 6.56 10.72 3333, 1748, 1678, 1647, 1613, 
64.08 6.35 10.91 1250br, 736, 695 
C36H 4sN30 s 66.75 7.00 6.49 3333, 1736, 1678, 1647, 1608, 1585, 
66.59 7.13 6.76 1534, 1508, 1252br, 734, 694 
C39H43N30 s 68.70 6.36 6.16 3333, 1727, 1684, 1642, 1582, 
68.94 6.65 6.18 1527br, 1244br, 735, 694 
CssH 43Ns01 66.94 6.36 10.27 3333, 1689, 1634, 1536br, 1508br, 
66.70 6.66 10.50 1282br, 1258br, 1230br, 742, 695 
C14H24N604 · H 20 46.91 7.31 23.45 
46.53 7.70 23.03 
C14H 24N60 4 · H20 46.91 7.31 23.45 
46.58 7.66 23.09 
C21H30N60 s 56.49 6.77 18.82 
56.19 7.11 18.57 
Cs1H3sN60 s 59.79 6.15 13.50 3390, 1748, 1695, 1653, 1639, 1536br, 
59.61 6.38 13.70 1266br, 1250br, 757, 738, 698 
C13H3sN60 s 59.79 6.15 13.50 3413, 1748, 1692, 1639, 1534br, 
59.92 6.33 13.75 1247br, 755, 698 
C45HsoN 60 9 · H 20 64.64 6.26 10.04 3333, 1748br, 1695, 1639, 
64.66 6.47 10.28 1538br, 1515br, 740, 696 
C2sH 40N60 s 57.13 6.85 14.28 3390, 1739, 1689. 1653, 1634, 1527br, 
57.17 6.67 14.57 1269br, 1250br, 752, 748, 702 
C43H 53N1010 62.38 6.45 11.84 3322, 1745br, 1689, 1675, 
62.67 6.60 12.03 1538br, 1261br, 732, 694 
C51H54N60 9 68.43 6.08 9.39 3289, 1715, 1672, 1631, 1539br, 
68.57 6.21 9.77 1504br, 1252br, 736, 683 
C21H30N60s 56.49 6.77 "18.82 
56.21 7.09 18.53 
C59H6sNs012 65.55 6.34 10.37 
65.41 6.61 10.47 
C21H 42Ns0 6 56.43 7.37 19.50 3417, 1738br, 171lbr, 1688, 1649, 
56.28 7.59 19.37 1531br, 1513br, 1260br, 733, 688 
• S y ponification/H y d r og enolysis 
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A similar series of reactions (Scheme 3) using the dipeptide derivatives 
VI and XV furnished N-benzyloxycarbonyl-0-benzyl-L-tyrosyl-L-histidyl-N-r-
-benzy loxycarbony 1-L-lysy 1-N-£-benzy loxycarbony 1-L-lysine methy 1 ester (XX). 
The saponification of this tetrapeptide derivative followed by hydrogenolysis 
in ethanol gave L-tyrosyl-L-histidy l-L-lysyl-L-lysine (XXI). 
The N-benzyloxycarbonyl-dipeptide methyl ester IV-VI and N-t-butoxy-
carbonyl-dipeptide esters XV and XVI, used for tri- and tetra-peptide syntheses, 
were conveniently prepared by means of the N-hydroxysuccinimide esters16•17 
of N-(0)-protected amino acids. The N-t-butoxycarbonyl-0-benzyl derivatives 
of L-tyrosyl-L-histidine methyl ester (XXII) and L-tyrosyl-N-£-benzyloxycarbo-
nyl-L-lysine methyl ester (XXIII) and N-benzyloxycarbonyl-0-benzyl-L-tyrosyl-
-N-£-benzyloxycarbonyl-L-lysine methyl ester (XXIV) were also prepared to 
be used in the synthesis of further analogs which will be the subject of a 
forthcoming paper. 
EXPERIMENTAL 
Melting points, uncorrected were taken on a Kofler hot stage. IR spectra were 
recorded in potassium bromide pellets using a Perkin-Elmer lnfracord model 137. 
RF values were measured by silica gel TLC [Merck, HF254, type 60; developed in 
methylene chloride-methanol (9 : 1)). The products were rendered visible by use 
of a ninhydrin spray. t-Butoxycarbonyl and benzyloxycarbonyl- amino acids N-hydro-
xysuccinimide esters were purchased from »Fluka«, Chemical Co., Buchs, CH. 
N-BenzyloxycarbonyL- (or N-t-butoxycarbonyL-) Peptide MethyL (or Benzyl) 
Esters. GeneraL procedures 
Dipeptide derivatives VI, IX, XV, XVI, XXII-XXV. - A suspension of 
N-hydroxysuccinimide ester of glycine or 0-benzyl-L-tyrosine as its N-benzyloxy-
carbonyl or N-t-butoxycarbonyl derivative, or the N-hydroxysuccinimide ester of 
N-t-butoxycarbonyl-N-e-benzyloxycarbonyl-L-lysine (1 mmol) in dimethylformamide 
(10-20 ml), dioxane (6.5 ml) or 1,2-dimethoxyethane (10 ml) was treated with the 
hydrochloride of L-histidine methyl ester or N-E-benzyloxycarbonyl-L-lysine methyl 
(or benzyl) ester (1.1 mmol) in the presence of triethylamine (1.2 mmol) as outlined 
in Schemes 1 and 2. Triethylamine hydrochloride was filtered off and the filtrate 
stired at 70 °C for 5 h at room temperature for 24 h and then evaporated to dryness 
at 30 °c and 10-2 mm Hg. The residue was dissolved in 100/o citric acid and partitioned 
with ethylacetate. The ethylacetate extract was washed with 0.2 mol dm-3 NaHC0,1, 
water, and then evaporated to dryness. The products crystallized in 62-91.60/o 
yields (see Table I) . 
Hydrazides of Dipeptide Derivatives IX, XXV. - To a solution of N-benzyloxy-
carbonyl-0-benzyl-L-tyrosyl-L-histidine methyl ester (VI) or N-benzyloxycarbonyl-
-0-benzyl-L-tyrosyl-N-E-benzyloxycarbonyl-L-lysine methyl ester (XXIV) (1 mmol) 
in anhydrous methanol (5 ml) hydrazine monohydrate (1 ml) was added. The mixture 
was kept at room temperature for 24 h or refluxed for 1 h. The product precipitated 
in 85-880/o yields (see Table I). 
Tripeptide Derivatives I-III, X-XIII, XVII-XIX. - To a O 0c cooled solution 
of the hydrazide of N-benzyloxycarbonyl- (or N-t-butoxycarbonyl-) glycyl-L-histidine 
(IV, XIV), N-benzyloxycarbonyl-glycyl-N-s-benzyloxycarbonyl-L-lysine (V), N-ben-
zyloxycarbonyl-0-benzyl-L- tyrosyl-L-histidine (VI), or N-benzyloxycarbonyl-L-histi-
dine (1 mmol) in 1 mol dm-3 HCl (3 ml) ethylacetate (5 ml), and sodium nitrite (1 
mmol) dissolved in water (0 .5 ml) was adde-d. The mixture was stirred for 5 min 
and then treated with 500/o potassium c2.rbonate (2.5 ml). The ethylacetate layer, con-· 
taining generated azide, combined with the freshly prepared ethylacetate solution 
(3 ml) of N-E-benzyloxycarbonyl-L-lysine methyl ester, L-histidine methyl ester, 
N-e-benzyloxycarbonyl-L-lysyl-N-E-benzyloxycarbonyl-L- lysine methyl ester, or 0-
-benzyl-L-tyrosyl-N-e-benzyloxycarbonyl-L-lysine benzyl ester, (1 mmol) (see Scheme 
2). The mixture was kept at O 0c for 1-4 days. A precipitate separated which was 
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extracted with ethylacetate. The ethylacetate extract was washed with 50/0 citric 
acid, 0.2 mol dm-3 NaHC03, and water, and then evaporated to dryness under 
reduced pressure giving the products in 34.2-750/o yields. For details see Table I. 
Tetrapeptide Derivative XX. ______: The hydrazide of N-benzyloxycarbonyl-0-benzyl-
-L-tyrosyl-L-histidine (0.66 mmol) in 1 mol dm-3 HCl (2 ml) and ethylacetate (5 ml) 
was treated with sodium nitrite (0.66 mmol) in water (0.3 ml) . The azide produced 
was added to N-e-benzyloxycarbonyl-L-lysyl-N-e-benzyloxycarbonyl-L-lysine methyl 
ester (0.66 mmol). The mixture was kept for 4 days and treated as described for 
the synthesis of the tripeptide derivatives. It gave N-benzyloxycarbonyl-0-benzyl-
-L-tyrosyl-L-histidyl-N-e-benzyloxycarbonyl-L-lysyl-N- e-benzyloxycarbony 1-L-lysine 
methyl ester (XX) in 880/o yield (see Table I). 
Deprotection of Tri- and Tetra-peptide Derivatives. General procedure 
The N-benzyloxycarbonyl tripeptide X-XII or tetrapeptide XX as its methyl 
ester (1 mmol) was dissolved in methanolic 1 mol dm-3 NaOH (1.5 ml), stirred at 
room temperature fo r 4 h, and then diluted with water (18 ml). This solution was 
acidified with 1 mol dm-3 HCl and left at 0 °c for 16 h. The N-benzyloxycarbonyl 
tripeptide either precipitated or was obtained after evaporation to dryness under 
reduced pressure in 59-1000/o yields. The free acid obtained (0.33 mmol) or N-ben·· 
zyloxycarbonyl-tripeptide XVIII (as benzyl ester), previously purified from anhy-
drous ethanol was dissolved in ethanol (25 ml) and hydrogeneated over · 100/o Pd/C 
(20 mg) and Pd-black (60 mg) until evolution of carbon dioxide was complete. The 
catalyst was filtered off and the filtrate repeatedly lyophilized and dissolved in 
water to yield chromatographycally pure glycyl-L-histidyl-L-lysine (I), glycyl-L-lysyl-
-L-histidine (II), L-tyrosyl-L-histidyl-·L-lysine (III), L-histidyl-L-tyrosyl-L-lysine (XIX), 
and L-tyrosyl-L-histidyl-L-lysyl-L-lysine (XXI) (see Table I). 
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SAZETAK 
Polifunkcionalni tri- i tetra-peptidi s Iizinom kao komponentom 
v. Skaric, J. Makarevic i fJ . Skaric 
Opisana je sinteza glicil-L-histidil-L-lizina, glicil-L-lizil-L-histidina, L- tirozil-L-
-histidil-L-lizina, N-,N- E,-N-E-tribenziloksikarbonil derivata L-histidil-L-lizil- - lizin 
metil estera, L-histidil-L-tirozil-L-lizina i L-tirozi l-L-histidil-L-lizil- ·L-lizina primjenom 
azidne metode. 
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